Works matching AU h:

Results: 5000
    1

    Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients.

    Published in:
    Hemodialysis International, 2012, v. 16, n. 1, p. 11, doi. 10.1111/j.1542-4758.2011.00608.x
    By:
    • Weinreich, Thomas;
    • Leistikow, Frank;
    • Hartmann, Hagen-Georg;
    • Vollgraf, Günter;
    • Dellanna, Frank;
    • Hartmann, H-G;
    • Leistikow, F;
    • Kunowski, G;
    • Hoffmann, H-D;
    • Vollgraf, G;
    • Holzmann, S;
    • Cernoch, K;
    • Garnier, E;
    • Fink, H;
    • Köthe, E;
    • Dose, U;
    • Meier, A;
    • Dammerboer, C;
    • Kohnle, M;
    • Koch, W
    Publication type:
    Article
    2

    Hospitalizations before and after initiation of chronic hemodialysis.

    Published in:
    Hemodialysis International, 2011, v. 15, n. 3, p. 341, doi. 10.1111/j.1542-4758.2011.00551.x
    By:
    • KASSAM, Hussein;
    • SUN, Yijuan;
    • ADENIYI, Muniru;
    • AGABA, Emmanuel I.;
    • MARTINEZ, Milagros;
    • SERVILLA, Karen S.;
    • RAJ, Doninic S.C.;
    • MURATA, Glen H.;
    • TZAMALOUKAS, Antonios H.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Chronic Hemodialysis in a Nigerian Teaching Hospital.

    Published in:
    Hemodialysis International, 2004, v. 8, n. 1, p. 87, doi. 10.1111/j.1492-7535.2004.0085v.x
    By:
    • Agaba, E. I.;
    • Lopez, A.;
    • Ma, I.;
    • Martinez, R.;
    • Tzamaloukas, R. A.;
    • Vanderjagt, D. J.;
    • Glew, R. H.;
    • Tzamaloukas, A. H.
    Publication type:
    Article
    10
    11

    Development and validation of a high throughput multiplex immunofluorescence assay to detect all human immunoglobulin isotypes and subclasses in human fluids.

    Published in:
    Journal of Immunology, 2025, v. 214, n. 4, p. 839, doi. 10.1093/jimmun/vkae048
    By:
    • Van Stigt, Arthur H;
    • Nederend, Maaike;
    • Smits, Gaby;
    • Kuijer, Marjan;
    • Schepp, Rutger M;
    • Van Gageldonk, Pieter G;
    • Hellinga, Anneke H;
    • Van Binnendijk, Robert S;
    • Bont, Louis J;
    • Van't Land, Belinda;
    • Den Hartog, Gerco;
    • Leusen, Jeanette H W;
    • PRIMA Initiative Group;
    • Knulst, André C;
    • Stahl, Bernd;
    • van der Ent, C Kors;
    • de Theije, Caroline G M;
    • van Baarle, Debbie;
    • van Wijk, Femke;
    • Linde, Hanneke
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Consensus nomenclature for CD8 T cell phenotypes in cancer.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.998538
    By:
    • Apetoh, Lionel;
    • Bonneville, Marc;
    • Butterfield, Lisa H.;
    • Caignard, Anne;
    • Castelli, Chiara;
    • Cavallo, Federica;
    • Celis, Esteban;
    • Chen, Lieping;
    • Dhodapkar, Madhav V.;
    • Colombo, Mario P.;
    • Comin-Anduix, Begoña;
    • Ribas, Antoni;
    • Coukos, Georges;
    • Romero, Pedro;
    • Speiser, Daniel E.;
    • Dranoff, Glenn;
    • Frazer, Ian H.;
    • Fridman, Wolf-Hervé;
    • Gabrilovich, Dmitry I.;
    • Gilboa, Eli
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Cell‐free DNA for detection and monitoring of extramedullary AML relapse.

    Published in:
    HemaSphere, 2025, v. 9, n. 3, p. 1, doi. 10.1002/hem3.70097
    By:
    • Hupe, Henri C.;
    • Wienecke, Clara P.;
    • Bartels, Stephan;
    • Schipper, Elisa;
    • Leßmann, Jannika;
    • Lasch, Alina;
    • Bader, Maximilian;
    • Gabdoulline, Razif;
    • Neugebohren, Martin;
    • Dammann, Elke;
    • Kreipe, Hans H.;
    • Lehmann, Ulrich;
    • Bergmann, Anke K.;
    • Di Donato, Nataliya;
    • Stadler, Michael;
    • Eder, Matthias;
    • Ganser, Arnold;
    • Heidel, Florian H.;
    • Thol, Felicitas;
    • Heuser, Michael
    Publication type:
    Article
    48

    Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry.

    Published in:
    HemaSphere, 2025, v. 9, n. 3, p. 1, doi. 10.1002/hem3.70090
    By:
    • Cho, Hyunyee Rosa;
    • Isfort, Susanne;
    • Kricheldorf, Kim;
    • Stegelmann, Frank;
    • Klausmann, Martine;
    • Heidel, Florian H.;
    • Griesshammer, Martin;
    • Schulz, Holger;
    • Hochhaus, Andreas;
    • Göthert, Joachim;
    • Schlag, Rudolf;
    • Hollburg, Wiebke;
    • Teichmann, Lino;
    • Sockel, Katja;
    • Wilop, Stefan;
    • Gezer, Deniz;
    • Kirschner, Martin;
    • Döhner, Konstanze;
    • Brümmendorf, Tim H.;
    • Koschmieder, Steffen
    Publication type:
    Article
    49
    50

    Characterization of Belantamab Mafodotin–Induced Corneal Changes in Patients With Multiple Myeloma.

    Published in:
    JAMA Ophthalmology, 2025, v. 143, n. 6, p. 507, doi. 10.1001/jamaophthalmol.2025.1008
    By:
    • Lee, Vivian;
    • Hultcrantz, Malin;
    • Petrone, Stephanie;
    • Lewis, Eric W.;
    • Banna, Hussam;
    • Lichtman, Eben;
    • Thulasi, Praneetha;
    • Quick, Anjulie A.;
    • Jeng, Bennie H.;
    • Sunshine, Sarah B.;
    • Francis, Jasmine H.;
    • Canestraro, Julia;
    • Farooq, Asim V.;
    • Clements, Peter;
    • Robertson, Nicola;
    • Burman, Mark;
    • McKevitt, Tom;
    • Struemper, Herbert;
    • Weir, Lucinda
    Publication type:
    Article